Emergence and Dissemination of Quinolone-Resistant Escherichia coli in the Community
- 1 November 1999
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (11) , 2736-2741
- https://doi.org/10.1128/aac.43.11.2736
Abstract
We studied the evolution of resistance to quinolones inEscherichia coli from 1992 to 1997 in Barcelona, Spain. An increasing proportion of quinolone-resistant E. coli (QREC) infections was observed. QREC strains were more common in patients with nosocomial infections but also increased in patients with community-acquired infections (9% in 1992 to 17% in 1996). Seventy (12%) of 572 episodes of E. coli bacteremia were due to QREC. Factors significantly associated with QREC bacteremia were the presence of underlying disease, recent exposure to antibiotics, and bacteremia of unknown origin. In the multivariate analysis, only prior exposure to antimicrobial agents (P < 0.001; odds ratio [OR] = 2), specifically, to quinolones (P < 0.001; OR = 14), and the presence of a urinary catheter (P < 0.001; OR = 2) were significantly associated with QREC bacteremia. Among 16 QREC isolates from cultures of blood of community origin selected at random, 13 different pulsed-field gel electrophoresis patterns were recognized, showing the genetic diversity of these isolates and in turn indicating the independent emergence of QREC in the community. The prevalence of QREC in the feces of healthy people was unexpectedly high (24% in adults and 26% in children). A survey of the prevalence of QREC of avian and porcine origin revealed a very high proportion of QREC in animal feces (up to 90% of chickens harbored QREC). The high prevalence of QREC in the stools of healthy humans in our area could be linked to the high prevalence of resistant isolates in poultry and pork.Keywords
This publication has 25 references indexed in Scilit:
- Molecular Epidemiological Analysis of Quinolone‐ResistantEscherichia coliCausing Bacteremia in Neutropenic Patients with Leukemia in KoreaClinical Infectious Diseases, 1997
- Antibiotic Resistance in Spain: What Can Be Done?Clinical Infectious Diseases, 1996
- Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy?Journal of Antimicrobial Chemotherapy, 1996
- Emergence of Quinolone-Resistant Escherichia coli Bacteremia in Neutropenic Patients with Cancer Who Have Received Prophylactic NorfloxacinClinical Infectious Diseases, 1995
- Editorial Response: Is Resistant Escherichia coli Bacteremia an Inevitable Outcome for Neutropenic Patients Receiving a Fluoroquinolone as Prophylaxis?Clinical Infectious Diseases, 1995
- Risk Factors for Acquisition of Urinary Tract Infections Caused by Ciprofloxacin Resistant Escherichia ColiJournal of Urology, 1995
- The emergence of highly fluoroquinolone-resistant Eschericha coli in community-acqntred urinary tract infectionsJournal of Antimicrobial Chemotherapy, 1992
- The Carriage ofEscherichia coliResistant to Antimicrobial Agents by Healthy Children in Boston, in Caracas, Venezuela, and in Qin Pu, ChinaNew England Journal of Medicine, 1990
- Mechanisms of resistance to quinolones and clinical perspectivesJournal of Antimicrobial Chemotherapy, 1989
- Social, Behavioral, and Practical Factors Affecting Antibiotic Use Worldwide: Report of Task Force 4Clinical Infectious Diseases, 1987